10517-16-5
10517-16-5
Chemical Structure
1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one
- CAS No.: 10517-16-5
- Formula:C10H12N4O5
- Molecular Weight:268.23
IUPAC Name: 9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one
InChIKey: UGQMRVRMYYASKQ-GAWUUDPSSA-N
SMILES: O[C@@H]1[C@@H](O)[C@@H](CO)O[C@H]1N(C=N2)C3=C2C(NC=N3)=O
Biological Activity: 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
